Neuphoria Therapeutics Inc. - Common Stock (NEUP)
3.6400
-0.2800 (-7.14%)
NASDAQ· Last Trade: Jul 25th, 1:26 AM EDT
On Friday, there are stocks with unusual volume. Let's take a look.chartmill.com
Via Chartmill · July 24, 2026
NEUP Shares Rise Pre-Market As It Explores Strategic Alternatives, Including Potential Acquisitionstocktwits.com
Via Stocktwits · November 11, 2025
Looking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · October 27, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
Via Chartmill · October 24, 2025
Why Did NEUP Stock Surge 64% Today?stocktwits.com
Via Stocktwits · October 24, 2025
Via Benzinga · October 24, 2025
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
Via Chartmill · October 24, 2025
Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via Chartmill · October 24, 2025
Via Benzinga · October 24, 2025
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · October 24, 2025
Via Benzinga · October 24, 2025
Let's explore the current happenings on the US markets on Wednesday. Below, you'll find the stocks exhibiting unusual volume in today's session.
Via Chartmill · October 22, 2025
Via Benzinga · October 21, 2025
Via Benzinga · October 21, 2025
Via Benzinga · October 21, 2025
Via Benzinga · October 21, 2025
Via Benzinga · October 20, 2025
Via Benzinga · October 16, 2025
Via Benzinga · September 23, 2025
Via Benzinga · August 27, 2025

This payment represents the second milestone in the collaboration between Neuphoria and Merck, with Neuphoria potentially eligible for up to $450 million in additional milestone payments.
Via Stocktwits · February 12, 2025


